Patients with moderate degrees of hyperglycaemia, patients without previous insulin therapy and elderly or frail patients at high risk of hypoglycaemia may be treated with a combination of DPP4i and basal insulin according to a recent therapeutic algorithm [23]. This evidence concerns the gene INS and Hypoglycemia.